Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
Journal of Hematology & Oncology
|
July 19, 2017
miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells
Graziella Cimino-Reale, Paolo Gandellini, Francesca Santambrogio, et al.
Biology Letters
|
July 26, 2013
Nestling telomere length does not predict longevity, but covaries with adult body size in wild barn swallows
Manuela Caprioli, Maria Romano, Andrea Romano, et al.
The Prostate
|
December 24, 2002
Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis
Linda Orlandi, Mara Binda, Marco Folini, et al.
Molecular Cancer Therapeutics
|
January 25, 2006
Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells
Francesco Paduano, Raffaella Villa, Marzia Pennati, et al.
European Journal of Medicinal Chemistry
|
June 4, 2019
Distinct biological responses of metastatic castration resistant prostate cancer cells upon exposure to G-quadruplex interacting naphthalenediimide derivatives
Marta Recagni, Maria Laura Greco, Andrea Milelli, et al.
Biochemical Pharmacology
|
March 9, 2010
Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer
Marco Folini, Claudia Pivetta, Giuseppe Zagotto, et al.
Cell Death & Disease
|
November 27, 2022
Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres
Natalia Maciejewska, Mateusz Olszewski, Jakub Jurasz, et al.
Carcinogenesis
|
May 29, 2003
Inhibition of telomerase activity by geldanamycin and 17-allylamino, 17-demethoxygeldanamycin in human melanoma cells
Raffaella Villa, Marco Folini, Chiara Della Porta, et al.
Cancer Research
|
July 4, 2003
Photochemical internalization of a peptide nucleic acid targeting the catalytic subunit of human telomerase
Marco Folini, Kristian Berg, Enrico Millo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 2, 2005
Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells
Marco Folini, Cinzia Brambilla, Raffaella Villa, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
Journal of Hematology & Oncology
|
July 19, 2017
miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells
Graziella Cimino-Reale, Paolo Gandellini, Francesca Santambrogio, et al.
Biology Letters
|
July 26, 2013
Nestling telomere length does not predict longevity, but covaries with adult body size in wild barn swallows
Manuela Caprioli, Maria Romano, Andrea Romano, et al.
The Prostate
|
December 24, 2002
Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis
Linda Orlandi, Mara Binda, Marco Folini, et al.
Molecular Cancer Therapeutics
|
January 25, 2006
Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells
Francesco Paduano, Raffaella Villa, Marzia Pennati, et al.
European Journal of Medicinal Chemistry
|
June 4, 2019
Distinct biological responses of metastatic castration resistant prostate cancer cells upon exposure to G-quadruplex interacting naphthalenediimide derivatives
Marta Recagni, Maria Laura Greco, Andrea Milelli, et al.
Biochemical Pharmacology
|
March 9, 2010
Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer
Marco Folini, Claudia Pivetta, Giuseppe Zagotto, et al.
Cell Death & Disease
|
November 27, 2022
Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres
Natalia Maciejewska, Mateusz Olszewski, Jakub Jurasz, et al.
Carcinogenesis
|
May 29, 2003
Inhibition of telomerase activity by geldanamycin and 17-allylamino, 17-demethoxygeldanamycin in human melanoma cells
Raffaella Villa, Marco Folini, Chiara Della Porta, et al.
Cancer Research
|
July 4, 2003
Photochemical internalization of a peptide nucleic acid targeting the catalytic subunit of human telomerase
Marco Folini, Kristian Berg, Enrico Millo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 2, 2005
Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells
Marco Folini, Cinzia Brambilla, Raffaella Villa, et al.
Page
of 7